Business Context and Reporting Period
This filing is a Form 6-K submitted by GSK Plc on October 30, 2002. The document announces a corporate governance change effective immediately, specifically the separation of the Remuneration & Nominations Committee into two distinct committees.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on board committee restructuring.
Material Changes
The primary material change is the structural reorganization of the Board's committees:
- Remuneration Committee: Established with Paul Allaire as Chairman. Other members include Sir Roger Hurn, Michele Barzach, John McArthur, and Donald McHenry.
- Nominations Committee: Established with Sir Christopher Hogg as Chairman. Other members include Sir Roger Hurn, Sir Ian Prosser, John McArthur, and Donald McHenry.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, risk factors, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation of the effective date for the new committee structures.
- Verification of the specific roles and responsibilities assigned to the new Remuneration and Nominations Committees.
- Review of subsequent filings to ensure no other governance changes were omitted from this brief announcement.